Body weight-based dosing around 4-6mcg per kilogram provides individualized starting points
In a double-blind, placebo-controlled, multi-center clinical study in Italy, 2,330 patients with an acute front wall infarction received either an L-carnitine preparation (9 g/day intravenously for 5 days, 4 g/day orally for 6 months) or a placebo
However, no deleterious side effects have been reported in the literature thus far
Clinical observations suggest better muscle retention with combined therapy compared to tirzepatide alone, but no placebo-controlled trial has validated this
Tirzepatide binds to GLP-1 receptors in the brain and gut, mimicking and amplifying this natural fullness signal
[24] However these are not long-term solutions and should only be used occasionally with your doctors guidance